tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MLTX Stock Latest News

Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
The FlyCapricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
3d ago
CAPR
GILD
MoonLake Immunotherapeutics Announces Board Changes and Incentives
PremiumCompany Announcements
MoonLake Immunotherapeutics Announces Board Changes and Incentives
4d ago
8K
MLTX
MoonLake Immunotherapeutics management to meet with Oppenheimer
PremiumThe Fly
MoonLake Immunotherapeutics management to meet with Oppenheimer
1M ago
MLTX
MoonLake Immunotherapeutics announces first patients screened in IZAR program
PremiumThe Fly
MoonLake Immunotherapeutics announces first patients screened in IZAR program
1M ago
MLTX
MoonLake Immunotherapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
MoonLake Immunotherapeutics Reports Q3 2024 Financial Results
1M ago
MLTX
MoonLake Immunotherapeutics reports Q3 EPS (56c), consensus (43c)
PremiumThe FlyMoonLake Immunotherapeutics reports Q3 EPS (56c), consensus (43c)
2M ago
MLTX
MoonLake Immunotherapeutics sees cash runway into end of 2026
Premium
The Fly
MoonLake Immunotherapeutics sees cash runway into end of 2026
2M ago
MLTX
MoonLake Immunotherapeutics assumed with an Outperform at Wedbush
Premium
The Fly
MoonLake Immunotherapeutics assumed with an Outperform at Wedbush
2M ago
MLTX
MoonLake Immunotherapeutics Capital Markets Day Preview
PremiumCompany Announcements
MoonLake Immunotherapeutics Capital Markets Day Preview
3M ago
8K
MLTX
Boeing’s Starliner to return without astronauts: Morning Buzz
PremiumThe Fly
Boeing’s Starliner to return without astronauts: Morning Buzz
4M ago
W
X
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
4M ago
W
BJ
MoonLake Immunotherapeutics downgraded to at Wolfe on lower M&A odds
PremiumThe Fly
MoonLake Immunotherapeutics downgraded to at Wolfe on lower M&A odds
4M ago
MLTX
MoonLake downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyMoonLake downgraded to Peer Perform from Outperform at Wolfe Research
4M ago
MLTX
MoonLake Immunotherapeutics reports Q2 EPS (39c), consensus (28c)
Premium
The Fly
MoonLake Immunotherapeutics reports Q2 EPS (39c), consensus (28c)
5M ago
MLTX
MoonLake Immunotherapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
MoonLake Immunotherapeutics initiated with an Outperform at Oppenheimer
6M ago
MLTX
MoonLake Immunotherapeutics Advances in Psoriatic Arthritis Trial
PremiumCompany Announcements
MoonLake Immunotherapeutics Advances in Psoriatic Arthritis Trial
6M ago
8K
MLTX
MoonLake Immunotherapeutics announces regulatory feedback from FDA, EMA
PremiumThe Fly
MoonLake Immunotherapeutics announces regulatory feedback from FDA, EMA
7M ago
MLTX
MoonLake Immunotherapeutics starts Phase 3 VELA program of sonelokimab
PremiumThe Fly
MoonLake Immunotherapeutics starts Phase 3 VELA program of sonelokimab
7M ago
MLTX
MoonLake Immunotherapeutics sees cash runway to end of 2026
PremiumThe Fly
MoonLake Immunotherapeutics sees cash runway to end of 2026
8M ago
MLTX
MoonLake Immunotherapeutics announces anticipated events
PremiumThe FlyMoonLake Immunotherapeutics announces anticipated events
8M ago
MLTX
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
Premium
The Fly
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
8M ago
MLTX
3 Best Stocks to Buy Now, 4/29/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 4/29/2024, According to Top Analysts 
8M ago
VET
ACMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >